AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
1.075
-0.005 (-0.46%)
After-hours: Jun 27, 2025, 4:04 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $32.59 million as of June 27, 2025. Its market cap has decreased by -45.10% in one year.
Market Cap
32.59M
Enterprise Value
-34.47M
1-Year Change
-45.10%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $32.59M, a decrease of -88.41%. That is a compound annual growth rate of -48.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 32.59M | -20.96% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |